期刊
NATURE COMMUNICATIONS
卷 13, 期 1, 页码 -出版社
NATURE PORTFOLIO
DOI: 10.1038/s41467-022-35118-3
关键词
-
资金
- Marta and Owen Boris Foundation
- Ontario Ministry of Health
- Ontario Graduate Scholarship (OGS)
- McMaster Department of Surgery
- Division of Neurosurgery
- Ontario Institute for Cancer Research (OICR) Investigator Award by the Government of Ontario
- Natural Sciences and Engineering Research Council of Canada (NSERC)
- OICR Brain Tumor Translational Research Initiative
- National Cancer Institute [CA159859-07, P30 CA30199]
- Alex's Lemonade Stand Foundation
- William's Superhero Fund
- McDowell Charity Trust
- project CZ-OPENSCREEN: National Infrastructure for Chemical Biology [LM2018130]
- Bader Phillanthropies
- Canadian Institutes of Health Research (CIHR) Operating Grant
- Neurosurgical Research and Education Foundation (NREF)
- American Association of Neurological Surgeons (AANS), Pediatric Section
- Ontario Institute for Cancer Research (OICR)
- McMaster University Department of Surgery [R35 CA197699]
- California Institute for Regenerative Medicine interdisciplinary stem cell training program fellowship [T32 HL086344, T32 CA009523]
The RNA-binding protein Musashi-1 (MSI1) has been found to play an essential role in Group 3 (G3) medulloblastoma (MB), and its inhibition can effectively suppress tumor initiation and prolong survival in G3 MB mouse models and patient-derived xenografts. By identifying MSI1 binding targets in normal neural and G3 MB stem cells and cross-referencing them with large-scale screens at different levels, multiple MYC-associated pathways have been discovered to be selectively targeted by MSI1 in G3 MB, providing valuable resources for context-specific therapeutic strategies.
Pediatric medulloblastoma (MB) is the most common solid malignant brain neoplasm, with Group 3 (G3) MB representing the most aggressive subgroup. MYC amplification is an independent poor prognostic factor in G3 MB, however, therapeutic targeting of the MYC pathway remains limited and alternative therapies for G3 MB are urgently needed. Here we show that the RNA-binding protein, Musashi-1 (MSI1) is an essential mediator of G3 MB in both MYC-overexpressing mouse models and patient-derived xenografts. MSI1 inhibition abrogates tumor initiation and significantly prolongs survival in both models. We identify binding targets of MSI1 in normal neural and G3 MB stem cells and then cross referenced these data with unbiased large-scale screens at the transcriptomic, translatomic and proteomic levels to systematically dissect its functional role. Comparative integrative multi-omic analyses of these large datasets reveal cancer-selective MSI1-bound targets sharing multiple MYC associated pathways, providing a valuable resource for context-specific therapeutic targeting of G3 MB.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据